eFFECTOR Therapeutics, Inc. (EFTR) Stock Forecast
EFTR analyst forecast
as of October 21, 2026- Analyst consensus
- Strong buy 4.50 / 5 from 2 analysts
- Price target
- $10.00 average of analyst targets
- Upside to target
- +4,999,900.0% from the latest close
- Next earnings
- —
- 52-week range
- $0.00 – $0.00
EFTR analyst ratings
2 analystsNumber of analysts at each rating.
EFTR price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
EFTR earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; EFTR beat in 6 of 12.
What analysts expect from EFTR
2 analysts cover eFFECTOR Therapeutics; their consensus rating is strong buy (4.50 on a 1–5 scale, where 5 is a strong buy). The average price target is $10.00, 4,999,900.0% above the latest close of $0.00. eFFECTOR Therapeutics beat the EPS estimate in 6 of the last 12 quarters.
Related: EFTR income statement, EFTR key metrics, EFTR chart. See the EFTR stock overview for the latest quote and news.
EFTR forecast FAQ
What is eFFECTOR Therapeutics's price target?
The average analyst price target for eFFECTOR Therapeutics is $10.00, 4,999,900.0% above the latest close of $0.00.
Is eFFECTOR Therapeutics a buy, hold or sell?
Of 2 analysts covering eFFECTOR Therapeutics, 1 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
Does eFFECTOR Therapeutics usually beat earnings estimates?
eFFECTOR Therapeutics reported EPS at or above the analyst estimate in 6 of the last 12 quarters.